PureSoftware Ltd’s Post

In Life Sciences/Pharma manufacturing, outdated legacy systems often lead to inefficiencies and increased compliance risks. Relying on outdated technology can slow down production, create data silos, and jeopardize regulatory compliance—directly impacting both your bottom line and patient safety. Transition to modern, cloud-based systems that offer greater flexibility and scalability. Start by conducting a tech audit to identify critical areas that need upgrading. Companies that modernize their infrastructure report faster production cycles, improved compliance, and a significant boost in overall efficiency. 🔗 Research Article: https://lnkd.in/efPkjXFz Are legacy systems holding your operations back? Comment your expeerience below. #LifeSciences #PharmaManufacturing #TechUpgrade #DigitalTransformation #Productivity #Innovation #Growth

Real-world use cases of Google AI in #Healthcare: 1. Clinical Trials: Developing a new drug or pharmaceutical product takes ~12-15 years and costs around $1 billion. Bayer | Pharmaceuticals is exploring how to leverage #GenerativeAI technology to bring these products to market faster. 2. Clinical Documentation: Healthcare providers spend a lot of time on clinical documentation and workflows to support doctors and medical professionals. In partnership with Google Cloud, HCA Healthcare is currently implementing a pilot project that automatically extracts information from patient-doctor interactions and creates medical notes. 3. EHR Search & Summarizing: Patient records are often complex and stored in multiple systems, making it difficult to access information quickly. MEDITECH is Google AI technology to collect information from disparate sources and provide a detailed longitudinal view of the patient’s records. Learn more: https://lnkd.in/gR4nqMHQ

No matter where you are on your journey in GenAI, ONIX can partner with you and help achieve your next success.

New Waves in Clinical Trial Tech as there was some exciting news from the 2024 Veeva R&D and Quality Summit! Industry leaders gathered to unveil the latest innovations in clinical trial technologies, promising a brighter future in life sciences. One notable highlight was the keynote by Peter Gassner, Founder and CEO of Veeva Systems, who showcased Veeva's unwavering commitment to drive positive ROI for customers as a Public Benefit Corporation. This unique structure ensures Veeva's focus extends beyond profits to benefit the broader industry 🖥️ Gassner introduced Veeva's Development Cloud, Commercial Cloud, and Data Cloud. The standout was the debut of a new data product for clinical trials. It delivers centralized reference data for research sites, greatly simplifying the process for sponsors to identify suitable sites, leading to faster trial initiation. This is expected to revolutionize how data is managed and shared in clinical trials 💡 There was also great discussion on transforming clinical data management. Richard Young, VP at Veeva, emphasised the importance of interoperable platforms. This approach aims to simplify processes, reduce manual data entry, and enhance trial accuracy - very interesting, watch this space! #VeevaSystems #ClinicalTrials #LifeSciences #TechInnovation #ClinicalDataManagement #LifeScienceTech #ClinicalTrials #ClinicalResearch #ElixirAssociates #StaffinPartner

Impact on the Healthcare and Life Sciences Industry: Let's say you're a pharmaceutical company conducting groundbreaking research to develop life-saving medications. With Cadence's True Hybrid Cloud Solution powered by FSxN technology, they can seamlessly manage the vast datasets generated during drug discovery and clinical trials, accelerating the pace of innovation and improving patient outcomes. From precision medicine to population health management and drug development, healthcare and life sciences organizations can leverage Cadence's innovative solution to unlock new possibilities for research, diagnosis, and treatment in the ever-evolving healthcare landscape. This announcement emphasizes AWS, NetApp, and Cadence's commitment to driving technological advancement and empowering industries to thrive in the digital age. It's a game-changer for healthcare and life sciences, ushering in a new era of efficiency, collaboration, and transformative discovery in the realm of data management and cloud computing. 🌐💡 https://lnkd.in/ga97Aq-T

The switch to #CloudTechnology is particularly challenging for regulated industries like #pharma. This @RadBeeTwitt raises a great point: best practices should be organisation-specific. #DataIntegrity #Data

Is AI the key to healthcare innovation? Learn how Life Sciences Cloud is reshaping the industry.

Competition in drug discovery is fierce. Discover how this pharma giant gained a 25% edge by optimizing its Cloud Data Platform. Download the case study and learn their winning strategy. https://hubs.li/Q02sxK220 ##DrugDiscovery #PharmaInnovation #CaseStudy #DataOptimization

Salesforce recently announced the launch of Life Sciences Cloud, intended to streamline patient and healthcare professional (HCP) engagement as well as clinical, medical, and commercial operations with data, automation, and trusted AI. As the company furthers its investments in the space, Salesforce recently welcomed back Frank Defesche as SVP and GM of Life Sciences Cloud. He returns to Salesforce from Veeva Systems, where he worked closely with life sciences organizations spanning early-stage biotechs to top global pharmaceuticals. In this interview, Defesche outlines areas of growth for the industry, the biggest challenges facing life sciences organizations today, and how CRM and generative AI will provide new opportunities for life sciences organizations to engage with customers.

Salesforce recently announced the launch of Life Sciences Cloud, intended to streamline patient and healthcare professional (HCP) engagement as well as clinical, medical, and commercial operations with data, automation, and trusted AI. As the company furthers its investments in the space, Salesforce recently welcomed back Frank Defesche as SVP and GM of Life Sciences Cloud. He returns to Salesforce from Veeva Systems, where he worked closely with life sciences organizations spanning early-stage biotechs to top global pharmaceuticals. In this interview, Defesche outlines areas of growth for the industry, the biggest challenges facing life sciences organizations today, and how CRM and generative AI will provide new opportunities for life sciences organizations to engage with customers.